Skip to main content
. 2022 Jan 24;12:799833. doi: 10.3389/fendo.2021.799833

Table 2.

Metabolic analysis of the population studied.

Control group (n = 112) PCOS group (n = 104) p-value
FBG (mmol/L) 5.27 ± 0.37 5.23 ± 0.42 0.464
FINS (µIU/ml) 15.13 (15.23) 16.22 (15.94) 0.209
HOMA-IR 3.46 (4.08) 3.78 (3.94) 0.245
LDL (mmol/L) 2.64 ± 0.67 2.85 ± 0.67 0.030*
TG (mmol/L) 1.16 ± 0.67 1.37 ± 0.73 0.026*
HDL (mmol/L) 1.36 ± 0.32 1.27 ± 0.35 0.051
LDL/HDL 2.05 ± 0.76 2.37 ± 0.74 0.004**
ApoAI (mmol/L) 1.34 ± 0.19 1.32 ± 0.23 0.573
ApoB (mmol/L) 0.82 ± 0.20 0.89 ± 0.19 0.011*
ApoB/ApoAI 0.63 ± 0.19 0.70 ± 0.19 0.011*
TC (mmol/L) 4.19 ± 0.70 4.40 ± 0.80 0.048*
TC/HDL 3.22 ± 0.87 3.64 ± 0.95 0.001**

FBG, free blood-glucose; FINS, fasting insulin; LDL, low-density lipoprotein; TG, triglyceride; HDL, high-density lipoprotein; ApoAI, apolipoprotein AI; ApoB, apolipoprotein B; TC, total cholesterol; HOMA-IR = FBG * FINS/22.5.

*p < 0.05, **p < 0.01.